Cardiac hypertrophy is a common cardiovascular disease worldwide, and this study may provide novel potential therapeutic targets. The authors demonstrate that TINCR improves cardiac hypertrophy by acting as a competitive endogenous RNA for miR-211-3p and thus relieving its suppressive effects on the VEGFB-SDF-1α-CXCR4 signalling axis.
- Shan Tu
- Xiao-Yan Wang
- Zhi-Hui Zhang